BridgeMD
Compares treatment options for Presbyopia Correction
Official title A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery
ClinicalTrials.gov ID: NCT07232615
What this study is testing
- What it's testing
- To evaluate the clinical outcomes and patient satisfaction of two commercially available trifocal toric intraocular lenses Primary Objective: To compare the distance-corrected intermediate visual acuity between the two trifocal toric intraocular lenses. Secondary Objectives: To assess and compare the safety of two trifocal toric intraocular lenses.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Age of patient \>21 Years
- Patient diagnosed with cataract.
- Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry
- Calculated IOL power is within the range of investigational IOLs.
- Patient willing to sign inform consent form.
You likely can't join if
- Previous intraocular or corneal surgery.
- Traumatic cataract
- Pregnancy (as stated by patient) or lactation.
- Concurrent participation in another drug or device investigation.
- Irregular astigmatism.
- Patient receiving chlorquine treatment.
See the full eligibility criteria
- Age of patient \>21 Years
- Patient diagnosed with cataract.
- Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry
- Calculated IOL power is within the range of investigational IOLs.
- Patient willing to sign inform consent form.
- Clear intraocular media other than cataract.
- Female participants of childbearing potential must be willing to ensure that they use effective contraception during the study.
- Previous intraocular or corneal surgery.
- Traumatic cataract
- Pregnancy (as stated by patient) or lactation.
- Concurrent participation in another drug or device investigation.
- Irregular astigmatism.
- Patient receiving chlorquine treatment.
- people with any systemic disease that could increase operative risk or confound the outcome.
- Active ocular disease in the operative eye other than cataract.
- Vulnerable people as defined in section 12.3.9.
- Corneal Astigmatism \> 4.5 D
The study team makes the final eligibility decision.
Where it's taking place
- Düsseldorf, North Rhine-Westphalia, Germany
- Greven, North Rhine-Westphalia, Germany
- Rheine, North Rhine-Westphalia, Germany
- Bangalore, Karnatak, India
- Chennai, Tamil Nadu, India
- Córdoba, Córdoba, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Düsseldorf, North Rhine-Westphalia, Germany; Greven, North Rhine-Westphalia, Germany; Rheine, North Rhine-Westphalia, Germany; Bangalore, Karnatak, India; Chennai, Tamil Nadu, India; Córdoba, Córdoba, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.